Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016
NCT03469921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 602
Last updated 2018-03-19
Summary
Unicentric retrospective analysis of a cohort of 602 young adult and adolescent patients, aged 15 to 30 years, with haematological malignancies, and managed between 2000 and 2016
Conditions
- Malignant Haemopathies
- Acute Leukemia
- Non-hodgkin Lymphoma
- Hodgkin Lymphoma
Interventions
- DRUG
-
administered therapeutic regimens
administered therapeutic regimens
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Principal Investigators
-
Diane COSO · Institut Paoli-Calmettes
Eligibility
- Min Age
- 15 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-01
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- France
Study Locations
More Related Trials
-
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
NCT01794169 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
NCT01074047 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults
NCT00327678 ·Status: COMPLETED ·Phase: PHASE3
-
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
NCT03603795 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
NCT03035344 ·Status: UNKNOWN
-
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
NCT05811845 ·Status: RECRUITING
-
Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array
NCT02038361 ·Status: COMPLETED ·Phase: NA
-
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
NCT03597321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)
NCT00530699 ·Status: COMPLETED ·Phase: PHASE1
-
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
NCT03789981 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
NCT00195871 ·Status: UNKNOWN ·Phase: PHASE2
-
Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults
NCT02617004 ·Status: RECRUITING
-
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.
NCT03350152 ·Status: COMPLETED
-
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
NCT02577406 ·Status: COMPLETED ·Phase: PHASE3
-
Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia
NCT01785953 ·Status: UNKNOWN
-
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
NCT00460460 ·Status: TERMINATED ·Phase: PHASE1
-
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.
NCT03311815 ·Status: COMPLETED
-
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
NCT03284593 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
NCT04777916 ·Status: RECRUITING
-
Timed-Sequential Induction in CBF-AML
NCT00428558 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy
NCT02677922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
NCT02447666 ·Status: COMPLETED ·Phase: PHASE2
-
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
NCT01301820 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid Leukemia
NCT03433521 ·Status: COMPLETED
-
RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
NCT05127148 ·Status: RECRUITING